Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Repeat jCell Injection in RP
NCT04604899Phase 2Completed
- Sponsor
- jCyte, Inc.
- Start
- Dec 2020
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
A Phase 2 trial of famzeretcel in retinitis pigmentosa (RP), sponsored by jCyte, Inc.. Started Dec 2020; status: completed.
02
Drugs
famzeretcel
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT04604899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604899.